Philips finally managed to report robust quarterly results – beating estimates by an enviable margin. Growth was driven by D&T and CC, but partly offset by weaker PH. On top of this, supply-chain challenges have started easing. Most importantly, the turnaround plan unveiled by the new CEO seems promising. Apart from this, the testing results of the DreamStation1 devices also seem encouraging so far. Overall, a major re-rating is underway, and its sustenance is now dependent on the FDA’s (final) ....
31 Jan 2023
Strong end to 2022 + promising takeaways
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong end to 2022 + promising takeaways
Philips finally managed to report robust quarterly results – beating estimates by an enviable margin. Growth was driven by D&T and CC, but partly offset by weaker PH. On top of this, supply-chain challenges have started easing. Most importantly, the turnaround plan unveiled by the new CEO seems promising. Apart from this, the testing results of the DreamStation1 devices also seem encouraging so far. Overall, a major re-rating is underway, and its sustenance is now dependent on the FDA’s (final) ....